U.S. flag

An official website of the United States government

GRCh38/hg38 22q11.22(chr22:21981865-22202315)x3 AND See cases

Germline classification:
Likely benign (1 submission)
Last evaluated:
Sep 21, 2012
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000138625.5

Allele description [Variation Report for GRCh38/hg38 22q11.22(chr22:21981865-22202315)x3]

GRCh38/hg38 22q11.22(chr22:21981865-22202315)x3

Genes:
  • LOC130067043:ATAC-STARR-seq lymphoblastoid active region 18713 [Gene]
  • LOC130067045:ATAC-STARR-seq lymphoblastoid active region 18714 [Gene]
  • LOC130067046:ATAC-STARR-seq lymphoblastoid active region 18715 [Gene]
  • LOC130067047:ATAC-STARR-seq lymphoblastoid active region 18719 [Gene]
  • LOC130067048:ATAC-STARR-seq lymphoblastoid active region 18720 [Gene]
  • LOC130067050:ATAC-STARR-seq lymphoblastoid active region 18721 [Gene]
  • LOC130067051:ATAC-STARR-seq lymphoblastoid active region 18722 [Gene]
  • LOC130067052:ATAC-STARR-seq lymphoblastoid active region 18723 [Gene]
  • LOC130067044:ATAC-STARR-seq lymphoblastoid silent region 13520 [Gene]
  • LOC130067049:ATAC-STARR-seq lymphoblastoid silent region 13522 [Gene]
  • LOC130067053:ATAC-STARR-seq lymphoblastoid silent region 13523 [Gene]
  • TOP3B:DNA topoisomerase III beta [Gene - OMIM - HGNC]
  • LOC125424390:Sharpr-MPRA regulatory region 1853 [Gene]
  • LOC112694768:Sharpr-MPRA regulatory region 76 [Gene]
  • IGL:immunoglobulin lambda locus [Gene - HGNC]
  • IGLV11-55:immunoglobulin lambda variable 11-55 (non-functional) [Gene - HGNC]
  • IGLV4-60:immunoglobulin lambda variable 4-60 [Gene - HGNC]
  • IGLV4-69:immunoglobulin lambda variable 4-69 [Gene - HGNC]
  • IGLV6-57:immunoglobulin lambda variable 6-57 [Gene - HGNC]
  • IGLV8-61:immunoglobulin lambda variable 8-61 [Gene - HGNC]
Variant type:
copy number gain
Cytogenetic location:
22q11.22
Genomic location:
Preferred name:
GRCh38/hg38 22q11.22(chr22:21981865-22202315)x3
HGVS:
  • NC_000022.11:g.(?_21981865)_(22202315_?)dup
  • NC_000022.10:g.(?_22336262)_(22556709_?)dup
  • NC_000022.9:g.(?_20666262)_(20886709_?)dup
Links:
dbVar: nssv1601844; dbVar: nssv1601907; dbVar: nssv1603336; dbVar: nssv1603931; dbVar: nssv1604319; dbVar: nssv1604740; dbVar: nsv915886
Observations:
6

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000178991ISCA site 4

See additional submitters

no assertion criteria provided
Likely benign
(Sep 21, 2012)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providednot providedyes6not providednot providednot providednot providedclinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]
PMID:
20466091
PMCID:
PMC2869000

Details of each submission

From ISCA site 4, SCV000178991.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
2not provided1not providednot providedclinical testing PubMed (1)
3not provided1not providednot providedclinical testing PubMed (1)
4not provided1not providednot providedclinical testing PubMed (1)
5not provided1not providednot providedclinical testing PubMed (1)
6not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providedDiscovery1not providednot providednot provided
2unknownyesnot providednot providedDiscovery1not providednot providednot provided
3unknownyesnot providednot providedDiscovery1not providednot providednot provided
4unknownyesnot providednot providedDiscovery1not providednot providednot provided
5unknownyesnot providednot providedDiscovery1not providednot providednot provided
6unknownyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: May 7, 2024